Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovery And Validation Of New Biomarkers In The Context Of Multiple Myeloma With t(4-14) and Relapse

NCT07482761 is registered in ClinicalTrials.gov with BIWAKO as lead sponsor.

NCT NCT07482761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07482761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovery And Validation Of New Biomarkers In The Context Of Multiple Myeloma With t(4-14) and Relapse
Lead sponsor
BIWAKO
Phase
Observational
Overall status
Not yet recruiting
Start date
July 5, 2026
Completion date
June 1, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and malignant plasma cell neoplasms